Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
American Journal of Cardiovascular Drugs
Metadata
Title
Therapeutic Potential of Renin Inhibitors in the Management of Cardiovascular Disorders
Author
Dr Alice Stanton
Publication date
01-11-2003
Publisher
Springer International Publishing
Published in
American Journal of Cardiovascular Drugs / Issue 6/2003
Print ISSN: 1175-3277
Electronic ISSN: 1179-187X
DOI
https://doi.org/10.2165/00129784-200303060-00002

Other articles of this Issue 6/2003

American Journal of Cardiovascular Drugs 6/2003 Go to the issue

Review Article

Cancer of the Heart

Review Article

Glycoprotein IIb/IIIa Receptor Antagonists

Therapy in Practice

Contrast Nephropathy

Acknowledgments

Acknowledgment

Original Research Article

Factors Influencing Family Physician Adherence to Hypertension Treatment Guideline Recommendations on the Initiation of Pharmacotherapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits